Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R44OD035392-01A1
Description
SBIR Phase Phase II award: "Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery" awarded to CRYOCRATE LLC in COLUMBIA, Missouri. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $1,863,241. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.gov